Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 6
1989 5
1990 3
1991 10
1992 8
1993 3
1994 1
1995 9
1996 2
1997 3
1998 7
1999 9
2000 2
2001 4
2002 4
2003 2
2004 2
2005 5
2006 3
2008 1
2009 1
2011 4
2012 1
2015 3
2017 1
2020 1
2023 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Apraclonidine and my pupil.
Cambron M, Maertens H, Crevits L. Cambron M, et al. Clin Auton Res. 2011 Oct;21(5):347-51. doi: 10.1007/s10286-011-0118-6. Epub 2011 Mar 8. Clin Auton Res. 2011. PMID: 21384091 Clinical Trial.
PURPOSE: Used in the diagnosis of Horner's syndrome, apraclonidine 1% dilatates the involved eye due to denervation supersensitivity. Recent literature suggests that in healthy volunteers, apraclonidine provokes a mild miotic effect. ...The first measurements were p …
PURPOSE: Used in the diagnosis of Horner's syndrome, apraclonidine 1% dilatates the involved eye due to denervation supersensitivity. …
Apraclonidine and LASIK.
Aslanides IM, Tsiklis NS, Pallikaris IG, Jankov MR, Coskunseven E, Ozkilic E. Aslanides IM, et al. Ophthalmology. 2005 Dec;112(12):2238; author reply 2244. doi: 10.1016/j.ophtha.2005.09.021. Ophthalmology. 2005. PMID: 16325717 Clinical Trial. No abstract available.
Efficacy of apraclonidine eye drops in treating ptosis secondary to myasthenia gravis: A pilot clinical trial.
Agha M, Ismail H, Sawaya R, Salameh J. Agha M, et al. Muscle Nerve. 2023 Aug;68(2):206-210. doi: 10.1002/mus.27851. Epub 2023 May 31. Muscle Nerve. 2023. PMID: 37259693 Clinical Trial.
In this study we evaluate the effect of apraclonidine in alleviating ptosis secondary to MG. METHODS: This clinical trial (NCT05045248) was done at the American University of Beirut Medical Center. ...All increases were statistically significant. DISCUSSION: Apraclonidi …
In this study we evaluate the effect of apraclonidine in alleviating ptosis secondary to MG. METHODS: This clinical trial (NCT0504524 …
TOPICAL APRACLONIDINE REDUCES PAIN AFTER INTRAVITREAL INJECTIONS: A Double-Blind Randomized Controlled Trial.
Lagstein O, Ben-Artzi N, Achiron A, Nemet A, Khreish M, Bartov E, Burgansky-Eliash Z. Lagstein O, et al. Retina. 2017 Aug;37(8):1575-1580. doi: 10.1097/IAE.0000000000001397. Retina. 2017. PMID: 27841849 Clinical Trial.

RESULTS: Mean pain score was 1.69 (SD 1.44) in the apraclonidine group and 3.28 (SD 2.27) in the control group (P < 0.001). Phakic patients had a greater pain reduction after topical apraclonidine (P < 0.001). Subconjunctival hemorrhage incidence was 41% in

…

RESULTS: Mean pain score was 1.69 (SD 1.44) in the apraclonidine group and 3.28 (SD 2.27) in the control group (P < 0.001). Phak

…
Influence of apraclonidine and pilocarpine alone and in combination on post laser trabeculoplasty pressure rise.
Dapling RB, Cunliffe IA, Longstaff S. Dapling RB, et al. Br J Ophthalmol. 1994 Jan;78(1):30-2. doi: 10.1136/bjo.78.1.30. Br J Ophthalmol. 1994. PMID: 7906539 Free PMC article. Clinical Trial.
Apraclonidine and pilocarpine have been shown to be effective in reducing the incidence of intraocular pressure (IOP) spikes following argon laser trabeculoplasty. ...Patients receiving regular pilocarpine to either eye were excluded. Seventy five eyes received either a …
Apraclonidine and pilocarpine have been shown to be effective in reducing the incidence of intraocular pressure (IOP) spikes followin …
Apraclonidine and argon laser trabeculoplasty.
Holmwood PC, Chase RD, Krupin T, Rosenberg LF, Ruderman JM, Tallman BA, Brodstein DE, Chopra H, Goldenfeld M. Holmwood PC, et al. Am J Ophthalmol. 1992 Jul 15;114(1):19-22. doi: 10.1016/s0002-9394(14)77407-0. Am J Ophthalmol. 1992. PMID: 1352428 Clinical Trial.
Sixty patients with medically uncontrolled open-angle glaucoma (intraocular pressure greater than 21 mm Hg) were randomly assigned to one of two treatment regimens with apraclonidine before undergoing 360-degree argon laser trabeculoplasty. One drop of apraclonidine …
Sixty patients with medically uncontrolled open-angle glaucoma (intraocular pressure greater than 21 mm Hg) were randomly assigned to one of …
Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine.
Coleman AL, Robin AL, Pollack IP, Rudikoff MT, Enger C, Mayer PR. Coleman AL, et al. Arch Ophthalmol. 1990 Sep;108(9):1264-7. doi: 10.1001/archopht.1990.01070110080029. Arch Ophthalmol. 1990. PMID: 2205182 Clinical Trial.
We performed a double-masked, crossover study comparing the cardiovascular and intraocular pressure effects of 0.5% and 0.25% topical apraclonidine hydrochloride and 0.5% timolol maleate in 20 healthy female volunteers. The contralateral effects of unilateral apraclonid …
We performed a double-masked, crossover study comparing the cardiovascular and intraocular pressure effects of 0.5% and 0.25% topical apr …
Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
Rosenberg LF, Krupin T, Ruderman J, McDaniel DL, Siegfried C, Karalekas DP, Grewal RK, Gieser DK, Williams R. Rosenberg LF, et al. Ophthalmology. 1995 Sep;102(9):1312-8. doi: 10.1016/s0161-6420(95)30869-x. Ophthalmology. 1995. PMID: 9097768 Clinical Trial.
Of patients with chronic angle-closure glaucoma, IOP was similar to prelaser values in 11 (69%) of 16 eyes treated with 0.5% (P > 0.7) and 12 (80%) of 15 eyes treated with 1.0% apraclonidine (P > 0.3). In patients undergoing capsulotomy, pressure was significantly lo …
Of patients with chronic angle-closure glaucoma, IOP was similar to prelaser values in 11 (69%) of 16 eyes treated with 0.5% (P > 0.7) an …
Effect of Apraclonidine and Diclofenac on Early Changes in Intraocular Pressure After Selective Laser Trabeculoplasty.
Thrane VR, Thrane AS, Bergo C, Halvorsen H, Krohn J. Thrane VR, et al. J Glaucoma. 2020 Apr;29(4):280-286. doi: 10.1097/IJG.0000000000001457. J Glaucoma. 2020. PMID: 32053556 Clinical Trial.
PReCIS:: Adjuvant diclofenac and apraclonidine eye drop given in conjunction with selective laser trabeculoplasty (SLT) do not significantly impact medium-term intraocular pressure (IOP) reduction compared with placebo, but apraclonidine can be used to blunt immedia …
PReCIS:: Adjuvant diclofenac and apraclonidine eye drop given in conjunction with selective laser trabeculoplasty (SLT) do not signif …
Reformulation and drop size of apraclonidine hydrochloride.
Vocci MJ, Robin AL, Wahl JC, Mayer P, Graves A, York B, Enger C, Sutton J. Vocci MJ, et al. Am J Ophthalmol. 1992 Feb 15;113(2):154-60. doi: 10.1016/s0002-9394(14)71527-2. Am J Ophthalmol. 1992. PMID: 1347973 Clinical Trial.
We performed a prospective, double-masked, placebo-controlled, six-period, cross-over study in which normal subjects were randomly assigned to treatment and compared three different formulations of apraclonidine hydrochloride (the present commercially available formulation …
We performed a prospective, double-masked, placebo-controlled, six-period, cross-over study in which normal subjects were randomly assigned …
104 results